Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

QT Prolongation Risk in Antihistamine Therapy

Guideline-Based Recommendations

  • The American College of Gastroenterology recommends choosing diphenhydramine over hydroxyzine in patients with cardiovascular risk factors, as diphenhydramine is notably absent from guideline lists of QT-prolonging medications that require routine cardiac monitoring 1
  • The European Society of Cardiology guidelines suggest avoiding concomitant QT-prolonging medications when hydroxyzine must be used despite risk factors, and monitoring QTc after dose changes 2
  • The European Society of Cardiology also recommends particular caution with hydroxyzine in elderly patients 2

Clinical Decision Making

  • For patients requiring antihistamine therapy with cardiovascular risk factors, the European Society of Cardiology suggests choosing diphenhydramine over hydroxyzine, or selecting alternative antihistamines (fexofenadine, desloratadine) 1
  • If hydroxyzine must be used despite risk factors, the European Society of Cardiology recommends avoiding concomitant QT-prolonging medications 2

QT Prolongation with Antihistamines

Introduction to QT Prolongation Risk

  • The American Academy of Pediatrics recommends that hydroxyzine is explicitly listed in pediatric guidelines as a QT-prolonging antihistamine alongside loratadine 3, 4
  • The British Journal of Dermatology guidelines suggest considering alternative antihistamines (fexofenadine, desloratadine) in patients with multiple risk factors 5, 6

Clinical Management Recommendations

  • Obtain baseline ECG before initiating hydroxyzine therapy in any patient with cardiovascular risk factors, and monitor QTc at baseline and after dose adjustments, with particular attention to QTc >500 ms or increases >60 ms from baseline 7
  • Correct electrolyte abnormalities (potassium <4.5 mEq/L, hypomagnesemia) before starting hydroxyzine therapy 7